HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intercepting the Lipid-Induced Integrated Stress Response Reduces Atherosclerosis.

AbstractBACKGROUND:
Eukaryotic cells can respond to diverse stimuli by converging at serine-51 phosphorylation on eukaryotic initiation factor 2 alpha (eIF2α) and activate the integrated stress response (ISR). This is a key step in translational control and must be tightly regulated; however, persistent eIF2α phosphorylation is observed in mouse and human atheroma.
OBJECTIVES:
Potent ISR inhibitors that modulate neurodegenerative disorders have been identified. Here, the authors evaluated the potential benefits of intercepting ISR in a chronic metabolic and inflammatory disease, atherosclerosis.
METHODS:
The authors investigated ISR's role in lipid-induced inflammasome activation and atherogenesis by taking advantage of 3 different small molecules and the ATP-analog sensitive kinase allele technology to intercept ISR at multiple molecular nodes.
RESULTS:
The results show lipid-activated eIF2α signaling induces a mitochondrial protease, Lon protease 1 (LONP1), that degrades phosphatase and tensin-induced putative kinase 1 and blocks Parkin-mediated mitophagy, resulting in greater mitochondrial oxidative stress, inflammasome activation, and interleukin-1β secretion in macrophages. Furthermore, ISR inhibitors suppress hyperlipidemia-induced inflammasome activation and inflammation, and reduce atherosclerosis.
CONCLUSIONS:
These results reveal endoplasmic reticulum controls mitochondrial clearance by activating eIF2α-LONP1 signaling, contributing to an amplified oxidative stress response that triggers robust inflammasome activation and interleukin-1β secretion by dietary fats. These findings underscore the intricate exchange of information and coordination of both organelles' responses to lipids is important for metabolic health. Modulation of ISR to alleviate organelle stress can prevent inflammasome activation by dietary fats and may be a strategy to reduce lipid-induced inflammation and atherosclerosis.
AuthorsUmut I Onat, Asli D Yildirim, Özlem Tufanli, Ismail Çimen, Begüm Kocatürk, Zehra Veli, Syed M Hamid, Kenichi Shimada, Shuang Chen, Jon Sin, Prediman K Shah, Roberta A Gottlieb, Moshe Arditi, Ebru Erbay
JournalJournal of the American College of Cardiology (J Am Coll Cardiol) Vol. 73 Issue 10 Pg. 1149-1169 (03 19 2019) ISSN: 1558-3597 [Electronic] United States
PMID30871699 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Dietary Fats
  • Eukaryotic Initiation Factor-2
  • Inflammasomes
  • Inflammation Mediators
  • Interleukin-1beta
Topics
  • Animals
  • Atherosclerosis (immunology)
  • Dietary Fats (metabolism)
  • Endoplasmic Reticulum (immunology)
  • Eukaryotic Initiation Factor-2 (metabolism)
  • Humans
  • Inflammasomes (metabolism)
  • Inflammation Mediators (metabolism)
  • Interleukin-1beta (metabolism)
  • Mice
  • Mitochondria (metabolism)
  • Oxidative Stress
  • Phosphorylation
  • Signal Transduction
  • Stress, Physiological (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: